Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Merck Shares Outstanding 2010-2024 | MKKGY

Merck shares outstanding history from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Merck shares outstanding for the quarter ending December 31, 2024 were 0.435B, a 80.02% decline year-over-year.
  • Merck 2024 shares outstanding were 0.435B, a 80.02% decline from 2023.
  • Merck 2023 shares outstanding were 2.176B, a 0.08% increase from 2022.
  • Merck 2022 shares outstanding were 2.174B, a 0% decline from 2021.
  
Merck Annual Shares Outstanding
(Millions of Shares)
2024 435
2023 2,176
2022 2,174
2021 2,174
2020 2,174
2019 2,174
2018 2,174
2017 2,174
2016 2,174
2015 2,174
2014 2,175
2013 2,174
2012 2,174
2011 2,174
2010 2,174
2009 2,174
Merck Quarterly Shares Outstanding
(Millions of Shares)
2024-12-31 435
2024-09-30 435
2024-06-30 2,174
2024-03-31 2,169
2023-12-31 2,176
2023-09-30 2,174
2023-06-30 2,173
2023-03-31 2,175
2022-12-31 2,174
2022-09-30 2,177
2022-06-30 2,174
2022-03-31 2,178
2021-12-31 2,174
2021-09-30 2,174
2021-06-30 2,174
2021-03-31 2,172
2020-12-31 2,174
2020-09-30 2,176
2020-06-30 2,164
2020-03-31 2,172
2019-12-31 2,174
2019-09-30 2,171
2019-06-30 2,174
2019-03-31 2,198
2018-12-31 2,174
2018-09-30 2,179
2018-06-30 2,167
2018-03-31 2,186
2017-12-31 2,174
2017-09-30 2,179
2017-06-30 2,170
2017-03-31 2,171
2016-12-31 2,174
2016-09-30 2,176
2016-06-30 2,167
2016-03-31 2,173
2015-12-31 2,167
2015-09-30 2,167
2015-06-30 2,173
2015-03-31 2,174
2014-12-31 2,188
2014-09-30 2,189
2014-06-30 2,174
2014-03-31 1,084
2013-12-31 2,175
2013-09-30 2,177
2013-06-30 2,174
2013-03-31 2,174
2012-12-31 2,174
2012-09-30 2,182
2012-06-30 2,174
2012-03-31 2,174
2011-12-31 2,174
2011-09-30 2,174
2011-06-30 2,174
2011-03-31 2,174
2010-12-31 2,174
2010-09-30 2,174
2010-06-30 2,184
2010-03-31 2,175
2009-12-31 2,174
2009-09-30 6,656
2009-06-30 2,170
2009-03-31 2,181
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $18.333B $22.569B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $83.131B 31.18
Zoetis (ZTS) United States $71.416B 26.65
Daiichi Sankyo, - (DSNKY) Japan $45.628B 23.21
Takeda Pharmaceutical (TAK) Japan $43.656B 8.68
Sandoz Group AG (SDZNY) Switzerland $19.760B 0.00
Summit Therapeutics (SMMT) United States $18.277B 0.00
United Therapeutics (UTHR) United States $13.896B 12.29
Shionogi (SGIOY) Japan $12.760B 12.78
Neurocrine Biosciences (NBIX) United States $11.566B 39.62
IPSEN (IPSEY) France $9.541B 0.00
Orion OYJ (ORINY) Finland $8.215B 22.22
Corcept Therapeutics (CORT) United States $7.486B 60.85
Stevanato Group S.p.A (STVN) Italy $7.395B 45.22
Madrigal Pharmaceuticals (MDGL) United States $6.558B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.976B 0.00
Grifols, S.A (GRFS) Spain $5.404B 0.00
Ionis Pharmaceuticals (IONS) United States $5.177B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.040B 10.32
Soleno Therapeutics (SLNO) United States $3.751B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.898B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.885B 10.11
Hypermarcas (HYPMY) Brazil $2.623B 17.26
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.325B 12.71
BioCryst Pharmaceuticals (BCRX) United States $2.105B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.059B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.833B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.665B 0.00
Guardian Pharmacy Services (GRDN) United States $1.560B 0.00
Indivior (INDV) United States $1.543B 6.54
Evotec AG (EVO) Germany $1.491B 0.00
Dyne Therapeutics (DYN) United States $1.375B 0.00
ARS Pharmaceuticals (SPRY) United States $1.311B 166.88
Ocular Therapeutix (OCUL) United States $1.115B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.057B 21.14
Enliven Therapeutics (ELVN) United States $0.983B 0.00
Harrow (HROW) United States $0.964B 0.00
Collegium Pharmaceutical (COLL) United States $0.958B 5.16
Avadel Pharmaceuticals (AVDL) Ireland $0.873B 0.00
Ardelyx (ARDX) United States $0.811B 0.00
Cronos Group (CRON) Canada $0.786B 0.00
Xeris Biopharma Holdings (XERS) United States $0.766B 0.00
AleAnna (ANNA) United States $0.655B 0.00
Akebia Therapeutics (AKBA) United States $0.651B 0.00
KalVista Pharmaceuticals (KALV) United States $0.579B 0.00
Xencor (XNCR) United States $0.577B 0.00
USANA Health Sciences (USNA) United States $0.554B 12.04
Regulus Therapeutics (RGLS) United States $0.543B 0.00
Bioventus (BVS) United States $0.536B 13.62
Savara (SVRA) United States $0.513B 0.00
CytoDyn (CYDY) United States $0.511B 0.00
Relay Therapeutics (RLAY) United States $0.485B 0.00
Elite Pharmaceuticals (ELTP) United States $0.458B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.446B 0.00
Altimmune (ALT) United States $0.444B 0.00
Zevra Therapeutics (ZVRA) United States $0.430B 0.00
Siga Technologies (SIGA) United States $0.424B 8.87
Amylyx Pharmaceuticals (AMLX) United States $0.400B 0.00
Organogenesis (ORGO) United States $0.400B 0.00
Tourmaline Bio (TRML) United States $0.399B 0.00
Verve Therapeutics (VERV) United States $0.371B 0.00
Oruka Therapeutics (ORKA) United States $0.360B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.327B 8.84
Heron Therapeutics (HRTX) United States $0.281B 0.00
Nature's Sunshine Products (NATR) United States $0.263B 24.29
ProKidney (PROK) United States $0.254B 0.00
Aquestive Therapeutics (AQST) United States $0.227B 0.00
MediWound (MDWD) Israel $0.215B 0.00
Avita Medical (RCEL) United States $0.185B 0.00
Nanobiotix S.A (NBTX) France $0.177B 0.00
OmniAb (OABI) United States $0.171B 0.00
Liminatus Pharma (LIMN) $0.171B 0.00
Inhibikase Therapeutics (IKT) United States $0.166B 0.00
Esperion Therapeutics (ESPR) United States $0.155B 0.00
4D Molecular Therapeutics (FDMT) United States $0.151B 0.00
Wellgistics Health (WGRX) United States $0.151B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.148B 0.00
Journey Medical (DERM) United States $0.146B 0.00
Korro Bio (KRRO) United States $0.146B 0.00
Nektar Therapeutics (NKTR) United States $0.132B 0.00
Aclaris Therapeutics (ACRS) United States $0.132B 0.00
Profound Medical (PROF) Canada $0.128B 0.00
Aldeyra Therapeutics (ALDX) United States $0.125B 0.00
Protara Therapeutics (TARA) United States $0.124B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Larimar Therapeutics (LRMR) United States $0.120B 0.00
Lyell Immunopharma (LYEL) United States $0.119B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.112B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.111B 0.00
OptiNose (OPTN) United States $0.096B 0.00
VAXART, INC (VXRT) United States $0.095B 0.00
Cardiol Therapeutics (CRDL) Canada $0.095B 0.00
Lexeo Therapeutics (LXEO) United States $0.094B 0.00
Achieve Life Sciences (ACHV) Canada $0.092B 0.00
Cassava Sciences (SAVA) United States $0.090B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.089B 0.00
Fractyl Health (GUTS) United States $0.087B 0.00
Champions Oncology (CSBR) United States $0.086B 14.19
Dominari Holdings (DOMH) United States $0.084B 0.00
Galectin Therapeutics (GALT) United States $0.083B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.083B 61.78
Telomir Pharmaceuticals (TELO) United States $0.082B 0.00
Arch Biopartners (ACHFF) Canada $0.080B 0.00
ESSA Pharma (EPIX) Canada $0.074B 0.00
Pyxis Oncology (PYXS) United States $0.074B 0.00
Context Therapeutics (CNTX) United States $0.074B 0.00
Unicycive Therapeutics (UNCY) United States $0.073B 0.00
Inotiv (NOTV) United States $0.072B 0.00
Nutriband (NTRB) United States $0.064B 0.00
Vivani Medical (VANI) United States $0.062B 0.00
Metagenomi (MGX) United States $0.060B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Assertio Holdings (ASRT) United States $0.058B 0.00
Gain Therapeutics (GANX) United States $0.057B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.051B 0.00
Mural Oncology (MURA) Ireland $0.046B 0.00
Century Therapeutics (IPSC) United States $0.045B 0.00
PMV Pharmaceuticals (PMVP) United States $0.044B 0.00
Prelude Therapeutics (PRLD) United States $0.044B 0.00
Karyopharm Therapeutics (KPTI) United States $0.043B 0.00
Avalo Therapeutics (AVTX) United States $0.040B 0.00
NRx Pharmaceuticals (NRXP) United States $0.039B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.039B 0.00
SCYNEXIS (SCYX) United States $0.038B 0.00
Rafael Holdings (RFL) United States $0.036B 0.00
Acrivon Therapeutics (ACRV) United States $0.035B 0.00
ElectroCore (ECOR) United States $0.035B 0.00
Iterum Therapeutics (ITRM) Ireland $0.033B 0.00
FibroGen (FGEN) United States $0.030B 0.00
PolyPid (PYPD) Israel $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Surrozen (SRZN) United States $0.024B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Mannatech (MTEX) United States $0.022B 0.00
Jupiter Neurosciences (JUNS) United States $0.021B 0.00
DURECT (DRRX) United States $0.020B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.020B 0.00
BioVie (BIVI) United States $0.020B 0.00
Vivos Therapeutics (VVOS) United States $0.018B 0.00
TherapeuticsMD (TXMD) United States $0.018B 0.00
GlycoMimetics (GLYC) United States $0.016B 0.00
Lipocine (LPCN) United States $0.015B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
Relmada Therapeutics (RLMD) United States $0.013B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
Plus Therapeutics (PSTV) United States $0.012B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.011B 1.99
Talphera (TLPH) United States $0.011B 0.00
BioLineRx (BLRX) Israel $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Ainos (AIMD) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Citius Pharmaceuticals (CTXR) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Traws Pharma (TRAW) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.006B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
Klotho Neurosciences (KLTO) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Incannex Healthcare (IXHL) Australia $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
Heatwurx (PCSA) United States $0.001B 0.00
SHINECO (SISI) China $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00